QIAGEN

QIAGEN is a multinational enterprise specialized in providing solutions for biological sample preparation, headquartered in Germany. Founded in Germany in 1984, QIAGEN was listed on NASDAQ in New York in 1996. Globally, QIAGEN has four regional headquarters in Asia-Pacific, Japan, North America, and Europe, with 19 subsidiaries, nearly 3,000 employees, more than 500 products, over 400,000 users, 409 approved patents, and more than 300 patent applications in progress. It is an industry leader in life science research, applied testing, and clinical diagnostics. As a leader in molecular detection technology and a major global supplier of biological molecular sample preparation solutions, QIAGEN (KaiJie Biotechnology) is renowned and widely recognized. Many biological scientists highly praise QIAGEN's technologies for biomolecule separation and purification, unanimously claiming that their research achievements benefit from QIAGEN's products and technologies.